Trial · NCT02331108

A Comparison of Inhalation vs. Intravenous Induction

NCT02331108, Not applicable, Completed, Albert Einstein Healthcare Network; results first posted 2017-04-17

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. A Comparison of Inhalation vs. Intravenous Induction. Trials, record NCT02331108. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02331108

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: A Comparison of Inhalation vs. Intravenous Induction
NCT number: NCT02331108
Status: Completed
Phases: Not applicable
Enrollment: 331 participants, actual
Lead sponsor: Albert Einstein Healthcare Network
Conditions: Hypothermia
Interventions: Selection of anesthetic induction technique
First posted: 2015-01-06
Last updated: 2017-04-17
Results first posted: 2017-04-17

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Measurement of Core Temperature	intraoperative	Core temperature at 15 minute intervals
Primary	Temperature Below 36.0 Degrees C	Intraoperative	Percentage of patients who had at least one temperature below 36.0 degrees C in the first hour of anesthesia
Secondary	Measurement of Blood Pressure	intraoperative	Blood pressure decrease after intravenous anesthetic induction

Source ClinicalTrials.gov

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Measurement of Core Temperature	intraoperative		degree C	MEAN
PRIMARY	Temperature Below 36.0 Degrees C	Intraoperative	Percentage of patients who had one core temperature reading below 36.0 degree C in the first hour of anesthesia	Percentage	NUMBER
SECONDARY	Measurement of Blood Pressure	intraoperative	Percentage of patients whose blood pressure decreased after propofol administration	percentage of patients	NUMBER

Source ClinicalTrials.gov

Results by group32

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units
Measurement of Core Temperature	Sevoflurane in 100% Oxygen, Age <56	15 minute temperature	36.42	Standard Deviation .49	degree C
Measurement of Core Temperature	Sevoflurane in 50% Nitrous, Age <56	15 minute temperature	36.44	Standard Deviation .44	degree C
Measurement of Core Temperature	Propofol, Age <56	15 minute temperature	35.96	Standard Deviation .40	degree C
Measurement of Core Temperature	Propofol With Phenylephrine, Age <56	15 minute temperature	36.35	Standard Deviation .38	degree C
Measurement of Core Temperature	Sevoflurane in 100% Oxygen, Age >55	15 minute temperature	36.34	Standard Deviation .46	degree C
Measurement of Core Temperature	Sevoflurane in 50% Nitrous, Age >55	15 minute temperature	36.41	Standard Deviation .52	degree C
Measurement of Core Temperature	Sevoflurane in 100% Oxygen, Age <56	30 minute temperature	36.41	Standard Deviation .49	degree C
Measurement of Core Temperature	Sevoflurane in 50% Nitrous, Age <56	30 minute temperature	36.48	Standard Deviation .44	degree C
Measurement of Core Temperature	Propofol, Age <56	30 minute temperature	35.95	Standard Deviation .41	degree C
Measurement of Core Temperature	Propofol With Phenylephrine, Age <56	30 minute temperature	36.36	Standard Deviation .40	degree C

1 to 10 of 32Source ClinicalTrials.gov

See all 32 results by group

Participant flow18

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	Sevoflurane in 100% Oxygen, Age <56	51
Overall Study	STARTED	Sevoflurane in 50% Nitrous, Age <56	52
Overall Study	STARTED	Propofol, Age <56	51
Overall Study	STARTED	Propofol With Phenylephrine, Age <56	51
Overall Study	STARTED	Sevoflurane in 100% Oxygen, Age >55	52
Overall Study	STARTED	Sevoflurane in 50% Nitrous, Age >55	52
Overall Study	COMPLETED	Sevoflurane in 100% Oxygen, Age <56	50
Overall Study	COMPLETED	Sevoflurane in 50% Nitrous, Age <56	50
Overall Study	COMPLETED	Propofol, Age <56	50
Overall Study	COMPLETED	Propofol With Phenylephrine, Age <56	50

1 to 10 of 18Source ClinicalTrials.gov

See all 18 participant flow

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals18

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Sevoflurane in 100% Oxygen, Age <56
Total, all-cause mortality	Sevoflurane in 50% Nitrous, Age <56
Total, all-cause mortality	Propofol, Age <56
Total, all-cause mortality	Propofol With Phenylephrine, Age <56
Total, all-cause mortality	Sevoflurane in 100% Oxygen, Age >55
Total, all-cause mortality	Sevoflurane in 50% Nitrous, Age >55
Total, other adverse events	Sevoflurane in 100% Oxygen, Age <56	0	51
Total, other adverse events	Sevoflurane in 50% Nitrous, Age <56	0	52
Total, other adverse events	Propofol, Age <56	0	51
Total, other adverse events	Propofol With Phenylephrine, Age <56	0	51

1 to 10 of 18Source ClinicalTrials.gov

See all 18 adverse event totals

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as
31694576	DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02331108

GET https://conductscience.org/api/trials/v1/NCT02331108/results?page=2

API reference For AI assistants